Sectoral Asset Management’s Contineum Therapeutics CTNM Stock Holding History

Sectoral Asset Management’s Portfolio CTNM Stock Details CTNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9M	Hold	727,587	–	–	8.32%	1
2026 Q1	$9.5M	Sell	727,587 -73,200	-9%	-$982K	7.87%	2
2025 Q4	$9.15M	Hold	800,787	–	–	7.34%	2
2025 Q3	$9.41M	Hold	800,787	–	–	5.81%	1
2025 Q2	$3.18M	Hold	800,787	–	–	2.1%	5
2025 Q1	$5.59M	Hold	800,787	–	–	4.35%	5
2024 Q4	$11.7M	Sell	800,787 -100	-0%	-$1.58K	7.83%	2
2024 Q3	$15.3M	Hold	800,887	–	–	9.05%	2
2024 Q2	$14.1M	Buy	+800,887	New	+$12.9M	5.73%	3

Other funds holding CTNM

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sectoral Asset Management's CTNM Position: Q2 2026 in Review

Sectoral Asset Management held its Contineum Therapeutics (CTNM) position steady in Q2 2026 at 727,587 shares worth $11.9M. The position accounts for 8.32% of the portfolio, ranked #1.

Sectoral Asset Management first reported a position in CTNM in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.3M in Q3 2024. 102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

Sectoral Asset Management held 727,587 shares of Contineum Therapeutics worth $11.9M as of Q2 2026.
Sectoral Asset Management left its Contineum Therapeutics share count unchanged in Q2 2026.
Contineum Therapeutics made up 8.32% of Sectoral Asset Management's portfolio in Q2 2026, its #1 holding.
Sectoral Asset Management first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 9 quarters since.
Sectoral Asset Management's Contineum Therapeutics position peaked at $15.3M in Q3 2024.
102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.